CompletedNCT02189057
A Pharmacokinetic/Pharmacodynamic Genetic Variation Treatment Algorithm Versus Treatment As Usual for Management Of Depression
Interventional studyAges 18–65United States
Understand this study
Who was this study for?
Listed age limits: 18 years to 65 years.
- Listed locations
- RochesterSee all locations and recruitment
Study information
Study start dateStarted: November 2014
- Recruitment status
- Completed
- Enrollment listed in the registry
- 160
- Sponsor
- Mayo Clinic
- Sponsor type
- Hospital / academic medical center
- Study type
- Other
- Intervention type
- OTHER
- Study phase
- Not clearly listed
- Locations
- United States
- Age range
- From 18 Years to 65 Years
- Official registry ID
- NCT02189057
- Official title
Show the full official title
A Pharmacokinetic/Pharmacodynamic Genetic Variation Treatment Algorithm Versus Treatment As Usual for Management of Depression
Get this study by email
Recruitment & locations
CompletedRochester
Questions about this study
Who is behind this study?
The study sponsor is Mayo Clinic, a hospital or academic medical center.
Who was this study for?
Listed age limits: 18 years to 65 years.
